JohnThomasO'MalleyMDPhD

Dermatology • Boston, MA

Assistant Professor, Brigham and Women's Hospital and Harvard Medical School

Join to view full profile

Dr. O'Malley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. O'Malley's full profile

Already have an account?

Office
221 Longwood Ave
# Brigham
Boston, MA 02115
Phone+1 617-732-4918

Fax+1 617-582-6060

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Dermatology, 2011 - 2014
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2010 - 2011
Indiana University School of MedicineClass of 2010

Certifications & Licensure

MA State Medical License 2014 - 2025
American Board of Dermatology Dermatology

Publications & Presentations

PubMed

29 citations
The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Yufen Zhao, L Wu, Qianjin Lu, X Gao, X. Zhu
The British Journal of Dermatology. 2021-08-06
12 citations
Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.
Amy S. Paller, Andreas Wollenberg, Elaine C. Siegfried, Diamant Thaçi, Michael J. Cork
Paediatric Drugs. 2021-05-18
37 citations
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label p...
Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Xian Sun
The British Journal of Dermatology. 2021-05-01

Lectures

Cutting Edge Multidisciplinary Care of the CTCL Patient
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Press Mentions

Press ReleasesDecember 9th, 2016